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Osteoclast-associated receptor blockade prevents
articular cartilage destruction via chondrocyte
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Osteoarthritis (OA), primarily characterized by articular cartilage destruction, is the most
common form of age-related degenerative whole-joint disease. No disease-modifying treat-
ments for OA are currently available. Although OA is primarily characterized by cartilage
destruction, our understanding of the processes controlling OA progression is poor. Here, we
report the association of OA with increased levels of osteoclast-associated receptor
(OSCAR), an immunoglobulin-like collagen-recognition receptor. In mice, OSCAR deletion
abrogates OA manifestations, such as articular cartilage destruction, subchondral bone
sclerosis, and hyaline cartilage loss. These effects are a result of decreased chondrocyte
apoptosis, which is caused by the tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) in induced OA. Treatments with human OSCAR-Fc fusion protein attenuates OA
pathogenesis caused by experimental OA. Thus, this work highlights the function of OSCAR
as a catabolic regulator of OA pathogenesis, indicating that OSCAR blockade is a potential
therapy for OA.
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Osteoarthritis (OA), the most common degenerative jointdisease afflicting the knee joints, is caused by many riskfactors1,2. OA is primarily characterized by chronic
inflammation and collagen degradation in the articular cartilage,
leading to progressive irreversible dysfunction3–6. Although stu-
dies have identified elements that are involved in the development
of OA, the importance of collagen recognition for cartilage
damage and regeneration is poorly understood.
Articular cartilage includes chondrocytes specifically respon-
sible for cartilage homeostasis and OA pathogenesis7–9. OA is
associated with the degradation of extracellular matrix molecules
such as collagen and aggrecan (ACAN) by the reduced ability of
chondrocytes to generate articular cartilage extracellular matrix
and the action of catabolic matrix-degrading enzymes10–12. OA
pathogenesis is also related to chondrocyte apoptosis and
reduction of tissue cellularity. Apoptotic chondrocytes are more
frequently found in cartilage lesions than in healthy tissues and
exhibit a proteoglycan deficiency13–15. However, the high rate of
cell death in cartilage is generally a rapid process, and the func-
tional relationship between OA and chondrocyte apoptosis is
difficult to assess.
Osteoclast-associated receptor (OSCAR) is an activating
receptor for collagen that co-stimulates osteoclast differentia-
tion16. OSCAR is an immunoglobulin (Ig)-like activating receptor
of the leukocyte receptor complex that is specifically expressed on
pre-osteoclasts. In osteoclasts, OSCAR is mediated by the
immunoreceptor tyrosine-based activation motif adaptor protein
FcRγ and co-stimulates osteoclasts cultured in an extracellular
matrix or collagen17,18. OSCAR contains two immunoglobulin-
like domains, D1 and D2. Recently D2, but not D1, was shown to
be critical for collagen binding19,20. In human rheumatoid
arthritis (RA), OSCAR is induced in monocytes, facilitating their
differentiation into osteoclasts and bone resorption21. OSCAR is
also expressed on the surrounding cells of synovial microvessels
and is upregulated in peripheral blood monocytes in relation to
disease activity21–23. In a recent study, the OSCAR–collagen
interaction induces an activating signal in monocyte-derived DCs,
which is relevant to RA pathogenensis24. However, limited
information is available on the effects of OSCAR in articular
cartilage. Moreover, there appears to be no experimental evidence
with respect to OSCAR function in osteoarthritic cartilage.
In this study, we examined whether OSCAR, a collagen-
recognition receptor, contributes to cartilage destruction during
OA. We found that the inhibition of OSCAR activity attenuated
the pathological changes of OA in the subchondral bone and
reduced the degeneration of articular cartilage in OA-induced
models. Besides, intra-articular (IA) injection of human OSCAR-
Fc protein in vivo blocks OA development. In this study, we
determined that blocking OSCAR may be the basis of a potential
disease-modifying therapy in OA.
Results
OSCAR is increased in OA chondrocytes. OSCAR is upregu-
lated in a range of myeloid cells, including osteoclasts17,18. We
detected OSCAR in the messenger RNA (mRNA) and protein of
chondrocytes in wild-type (WT) mice (Fig. 1a) but not in OSCAR
knockout (Oscar−/−) mice16, suggesting that OSCAR is also
expressed in nonmyeloid cells. We further investigated OSCAR
expression in chondrocytes of cartilage in an experimental OA
model in mice. Immunostaining revealed that the OSCAR protein
level was markedly elevated in chondrocytes in OA induced by
surgery performed for the destabilization of the medial meniscus
(DMM)25 (Fig. 1b, Supplementary Fig. 1a, b). Consistent with
increased protein levels, we found that Oscar mRNA expression
increased in mice with OA (Fig. 1b, Supplementary Fig. 1c).
Similarly, OSCAR was significantly increased in OA-affected,
damaged regions of human articular cartilage compared with
undamaged regions (Intact) of arthritic cartilage (Fig. 1c). Fur-
thermore, OSCAR was expressed in the early stages of OA, and
it was further induced during later stages (Supplementary
Fig. 1a, b). However, the expression of matrix-degrading enzymes,
including matrix metalloproteinases-3 and -13 (MMP3 and
MMP13), increased at 4 weeks following surgery (Supplementary
Fig. 1d–g). These findings suggest that OA-associated catabolic
events in mice and humans upregulate OSCAR expression in the
early stages of OA.
Genetic deletion of Oscar reduces OA pathogenesis. To explore
the possible association of OSCAR with OA pathogenesis initi-
ated by articular cartilage degradation at the articular surface,
we first induced experimental OA with collagenase26,27, which is
an enzymatic degradation model emulating the early stages of
articular cartilage damage in Oscar−/− mice. Important hallmarks
of OA pathology including articular cartilage destruction, sub-
chondral bone sclerosis, and hyaline cartilage loss, were sub-
stantially inhibited in Oscar−/− mice compared with that in WT
mice (Supplementary Fig. 2a–d). Moreover, the expression of
matrix-degrading enzymes, including Mmp3, Mmp13, and
Adamts5, were significantly decreased (Supplementary Fig. 2e),
whereas the transcript levels of type II collagen (Col2a1)
and Acan were increased in OA chondrocytes from Oscar−/−
mice (Supplementary Fig. 2f). Similarly, immunohistochemical
analysis revealed decreased expression of MMP3, MMP13,
and ADAMTS5, and upregulation of aggrecan and COL2A1
in OA chondrocytes from Oscar−/− mice (Supplementary
Fig. 2g, h).
We further investigated the in vivo role of OSCAR in OA
caused by DMM surgery, a commonly used surgical model in
mice25 that mimics clinical meniscal injury in the development of
human OA28,29 We found that Oscar−/− mice that underwent
DMM surgery exhibited significantly less articular cartilage
destruction, as determined by Osteoarthritis Research Society
International (OARSI) grade25,30 and safranin-O staining com-
pared with WT mice that underwent DMM surgery (Fig. 2a, b).
Other DMM-induced OA symptoms, such as subchondral bone
sclerosis, loss of hyaline cartilage, and calcification of the articular
cartilage zone, were also markedly reduced in Oscar−/− mice
(Fig. 2c, d). Three-dimensional microcomputed tomography
(μCT) analysis showed that subchondral bone plate (SBP)
thickness and bone volume were inhibited in Oscar−/− mice
compared with WT mice subjected to DMM surgery (Fig. 2e).
Consistent with these findings, OSCAR deficiency resulted in
downregulated expression of the extracellular matrix-degrading
enzymes, such as MMP3, MMP13, and ADAMTS5 (Fig. 2f, h),
and upregulation of aggrecan and COL2A1 (Fig. 2g, i). These
results collectively suggest that OSCAR is needed for OA
pathogenesis in mice.
OSCAR regulates TRAIL-induced chondrocyte apoptosis. To
identify regulatory factors in OA pathogenesis that are regulated
by OSCAR, we generated RNA-seq data for articular cartilage
obtained at 2- and 4 weeks after sham or DMM surgery in
Oscar−/− and WT mice. A total of 12,597 protein-encoding genes
with Transcripts Per Kilobase Million (TPM) values greater than
1 in at least one sample were used for differential gene expression
analysis (Supplementary Fig. 3a, b). As candidates for OSCAR
regulatory factors, we focused on the genes commonly attenuated
by Oscar deficiency at 2- and 4 weeks after surgery (Supple-
mentary Fig 3c, d). Among 1270 selected genes (Fig. 3a), func-
tional enrichment analysis of genes whose expression was altered
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by Oscar deficiency revealed epithelial–mesenchymal transition
(EMT), apoptosis, TGFβ signaling, IL2-STAT5 signaling, and
TNFα-NFκB signaling pathways (Fig. 3b). Expression of the EMT
gene, Mmp2 (encoding metalloprotease 2), the hypoxia gene,
Epas1 (encoding HIF2α), and the TNFα-NFκB pathway genes,
Nos2 and Ptgs2, were decreased in Oscar−/− mice (Supplementary
Fig. 3e). These genes were already known to be associated with
OA pathogenesis12,31,32.
Network analysis showed that cell death regulatory pathways
are involved in OSCAR-dependent OA (Fig. 3c). The gene
encoding tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL; Tnfsf10), which functions as a cell death-inducing
ligand33,34, was one of the significantly altered genes whose
expression was downregulated in OA chondrocytes in Oscar−/−
mice (Fig. 3c). Significant downregulation of TRAIL (encoded by
Tnfsf10) in OA chondrocytes in Oscar−/− mice was confirmed by
quantitative reverse transcription polymerase chain reaction
(Fig. 3d). DMM-induced upregulation of TRAIL levels in
articular cartilage was reduced in Oscar−/− mice compared with
that in WT mice (Fig. 3e). A decoy receptor, osteoprotegerin
(OPG encoded by Tnfrsf11b), binds to TRAIL35, resulting in the
suppression of the function of TRAIL to induce chondrocyte
apoptosis36,37. Thus, we investigated whether OSCAR also
regulates OPG expression in OA chondrocytes. Interestingly,
OPG mRNA was substantially decreased in mice with DMM-
induced OA (Fig. 3f). In addition, OPG levels were also markedly
decreased in the articular cartilage of mice with OA (Fig. 3g).
However, we found no significantly changes in the levels of OPG
mRNAs and proteins in OA chondrocytes in Oscar−/− mice,
indicating that OSCAR deficiency in mice prevents the reduction
of OPG expression (Fig. 3f, g). In addition, terminal deoxynu-
cleotidyl transferase dUTP nick-end labeling (TUNEL) staining
showed increased apoptosis in OA chondrocytes in WT mice
compared with that in Oscar−/− mice (Fig. 3h, i). Similar to OA
chondrocytes in mice, expression of Tnfsf10, but not Tnfrsf11b, as
well as chondrocyte apoptosis were increased in the damaged
regions of human OA patients (Supplementary Fig. 3g, h).
Collectively, these results strongly suggest that OSCAR recipro-
cally regulates TRAIL and OPG expression in OA chondrocytes
and is thereby responsible for increased chondrocyte apoptosis
during OA pathogenesis.
OSCAR affects chondrocyte apoptosis by collagen binding. The
direct role of OSCAR in apoptosis was further examined using the
primary cultures of murine articular chondrocytes. We examined
OSCAR expression in primary cultures of murine chondrocytes
stimulated with interleukin-1β (IL-1β) or tumor necrosis factor-α
(TNF-α), both of which are OA-associated pro-inflammatory
cytokines38. Treatment of IL-1β, but not TNF-α, moderately
increased the levels of OSCAR and TRAIL (Supplementary
Fig. 4a, b). However, pretreatment with collagenase, followed by
IL-1β treatment, markedly increased levels of OSCAR and
TRAIL, but not OPG, (Supplementary Fig. 4a, b) and further
induced chondrocyte apoptosis (Fig. 4a, Supplementary Fig. 4c).
Furthermore, IL-1β together with collagenase upregulated TRAIL
receptor DR5 (encoded by Tnfrsf10b), but not DcR1 (encoded by
Tnfrsf10c), DcR2 (encoded by Tnfrsf10d), or RANKL (encoded by
Tnfsf11) (Supplementary Fig. 4d). Interestingly, a TRAIL neu-
tralizing antibody downregulated expression of OSCAR and
TRAIL as well as cell death regulatory genes in chondrocytes
from WT, but not Oscar−/− mice, treated with IL-1β in the
presence of collagenase (Supplementary Fig. 4e–g).
To examine the stimulatory effects of OSCAR on chondrocyte
apoptosis, we knocked down Oscar using small inhibitory RNA
(siRNA). The knockdown of Oscar markedly decreased mRNA
and protein levels of TRAIL (Fig. 4b, c). Moreover, it inhibited IL-
1β-induced chondrocyte apoptosis (Fig. 4d, e). These effects were
inhibited by a soluble hOSCAR-Fc prepared by fusing the non-
cytoplasmic domain of human OSCAR to the Fc part of human
IgG1 (Fig. 4f, g). In addition, TUNEL staining showed that
hOSCAR-Fc efficiently blocks chondrocyte apoptosis (Fig. 4h).
Remarkably, we found that a minimal OSCAR-binding triple-
helical peptide, followed by IL-1β treatment, upregulated TRAIL
and reduced OPG. These peptide effects could be inhibited by
treatment of a soluble hOSCAR-Fc (Fig. 4i, j). Collectively, these
results suggest that OSCAR stimulation in chondrocytes is
responsible for the coordinate increase of TRAIL relative OPG,
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Fig. 1 OSCAR expression in mice and humans is upregulated in articular chondrocytes in OA. a Immunostaining for OSCAR protein (top) and mRNA
levels (bottom-right) in articular chondrocytes of Oscar−/− and WT mice. Error bars represent mean ± S.E.M. of n= 10 mice. Scale bar= 50 μm (top), 20
μm (bottom). b IHC (top) and qRT-PCR (bottom-right) analyses of OSCAR in articular cartilage of DMM surgery mice (compared to sham-operated mice).
Error bars represent mean ± S.E.M. of n= 10 mice. Scale bar= 50 μm (top), 20 μm (bottom). c Representative images show immunostaining (top) and
quantitative analyses (bottom-right) of OSCAR in intact and damaged regions of human OA articular cartilage. Error bars represent mean ± S.E.M. of n= 10
patient samples. Scale bar= 200 μm (top), 50 μm (bottom). Student’s two-tailed t test was used for statistical analysis, with p values displayed in figure.
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hence exerting a catabolic effect on chondrocytes under
conditions of collagen degradation.
OSCAR-Fc protects against articular cartilage degeneration. To
study the impact of OSCAR inhibition on experimental OA, we
used two OA mouse models: collagenase-induced OA mice and
mice that underwent DMM surgery. We injected hOSCAR-Fc
(2mg kg−1) or an isotype-matched IgG1 control (2mg kg−1) once
per week for 8 weeks in DMM-operated mice. In agreement with
our above data for Oscar−/− mice, the treatment of hOSCAR-Fc
significantly reduced all collagenase- or DMM-induced manifesta-
tions of OA, including articular cartilage destruction, subchondral
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articular cartilage zone (Fig. 5a–d, Supplementary Fig. 5a–d).
Moreover, expression of the matrix-degrading enzymes, MMP3,
MMP13, and ADAMTS5 and TRAIL, were decreased in OA
chondrocytes from hOSCAR-Fc-treated mice (Fig. 5e, g, Supple-
mentary Fig. 5e), whereas expression of type II collagen, aggrecan,
and OPG were increased by hOSCAR-Fc treatment (Fig. 5f, g,
Supplementary Fig. 5f). Furthermore, chondrocyte apoptosis was
markedly suppressed in OA chondrocytes from hOSCAR-Fc trea-
ted mice (Fig. 5h, i). The OSCAR-Fc derived from the murine Oscar
sequence (mOSCAR-Fc) exerted similar inhibitory effects on
experimental OA models (Supplementary Fig. 5g–i). These data
suggest that the OSCAR-Fc protein exerts its disease-modifying
effects on OA by blocking OSCAR.
Discussion
In the present study, we demonstrated that the OSCAR levels
increase during OA pathogenesis in human and mouse articular
cartilages. Oscar deficiency in mice prevents the development of
OA, lowers the expression levels of OA catabolic factors and
extracellular matrix molecules. Mechanistically, we found that
OSCAR regulates chondrocyte apoptosis during OA pathogen-
esis. Oscar knockdown or deficiency suppresses OA pathogenesis
by downregulating TRAIL, and reduced expression of TRAIL in
joint tissue inhibits OA cartilage destruction by blocking an
apoptotic signal in chondrocytes. Furthermore, OSCAR-Fc pro-
tein inhibited OA-induced cartilage destruction in mouse models,
suggesting that OSCAR may represent a therapeutic target
against OA.
Collagen is the most abundant protein present in mammals39.
In humans, various collagen subtypes are present in connective
tissues of diverse organs40 and exert an important role in cellular
functions such as proliferation, migration, and apoptosis41. In
RA, structural damage increases the turnover rate of collagen
within the joint, allowing interaction with immune cells42. For
example, monocytes expressing OSCAR have been detected in RA
synovium interacting with the exposed collagen16,22. To date, the
role of collagen-recognition receptors in OA pathogenesis has not
been clearly defined. A recent report indicated that the degra-
dation and decrease in COL2A1 may initiate and promote OA
progression43,44, which suggests that collagen degradation plays a
central role in the pathogenesis of OA.
OSCAR is expressed in myeloid cells, including monocytes,
macrophages, dendritic cells, and osteoclasts18,45–47. Osteoclasts
can bind to collagens exposed on bone surfaces to promote
osteoclast formation16. However, expression of OSCAR in
chondrocytes has not been reported previously. Therefore, we
hypothesized that cartilage collagen may become available for
interaction with OSCAR-expressing chondrocytes and may con-
siderably influence OA joints. Our results indicate that the
collagen–OSCAR interaction resulted in chondrocyte apoptosis to
promote OA development following mechanical injury induced
by DMM surgery in mice. Since the DMM model is most
representative of OA development following traumatic joint
injury in humans28,29, our findings suggest that traumatic OA
occurs as result of collagen–OSCAR binding. It will be of interest
to investigate whether OSCAR is involved in nontraumatic OA,
such as age-associated OA. Further studies on detailed OSCAR
expression and function in other subsets of OA are needed to
define the mechanistic basis for OA development.
To investigate the molecular mechanisms that regulate the
function of OSCAR in OA, we performed RNA-seq analysis to
search for OSCAR regulatory factor(s). We found that OSCAR is
closely related to TRAIL-mediated chondrocyte apoptosis in OA
pathogenesis. TRAIL is a type II transmembrane protein of the
TNF superfamily that triggers the apoptotic signaling cascade by
binding to either of the two cognate death receptors, TRAIL-R1/
DR4 and TRAIL-R2/DR5, which are expressed on the cell
surface36,48,49. Previous reports demonstrated the involvement of
TRAIL in the development of collagen-induced arthritis50,51. In
humans, normal articular chondrocytes express TRAIL receptors,
thereby modulating apoptosis. Moreover, cartilage obtained from
OA-induced rats showed increased expression of TRAIL36,37. In
addition, TRAIL binds to the decoy receptors, OPG, DcR1, and
DcR2, that either lack a death domain or contain a truncated
death domain35,49,52, and is thereby unable to activate an apop-
totic signal. In this study, we have shown that TRAIL is down-
regulated in articular cartilage of Oscar-deficient mice, thus
inhibiting chondrocyte cell death. Our results suggest a close
regulation between OSCAR and TRAIL as well as OPG during
OA pathogenesis. A recent study, using on an OPG transgenic
OA mouse, suggested that the administration of OPG prevents
chondrocyte apoptosis because of the ability of OPG to bind
TRAIL, an inducer of chondrocyte apoptosis53. Interestingly,
OPG was one of the altered genes whose expression was down-
regulated in Oscar−/− mice in the early stage of OA (Fig. 3c). In
WT mice, OPG expression was significantly decreased in the late
stage of OA, but Oscar deficiency maintained OPG expression
(Fig. 3f, g, Supplementary Fig. 3f). It will be important to define
the temporal relationship between TRAIL and OPG in the
development and progression of OA, including how OSCAR
reciprocally affects their expression.
To induce apoptosis in primary chondrocytes, we treated them
with IL-1β with collagenase. The effect of IL-1β on chondrocyte
apoptosis is controversial and appears to depend on experimental
conditions54–56. In humans, collagenase treatment of primary
chondrocytes induces chondrocyte apoptosis, which can be
inhibited by insulin-like growth factor-157. In this study, we
found that OSCAR is enhanced by collagenase, which causes the
upregulation of TRAIL, suppression of OPG expression, and
amplification of apoptotic signaling. These data suggest that
OSCAR may contribute to OA by epitope exposure of collagen.
Degradation of collagen fibers by collagenase generally leads to
exposure of embedded sequences in cartilage which can cause an
interaction with OSCAR and consequently apoptosis of chon-
drocytes. We confirmed that the minimal binding motif of col-
lagen induces OSCAR expression and higher TRAIL-mediated
chondrocyte apoptosis. In conclusion, collagen–OSCAR binding
can be considered as a damage-related molecular pattern signal in
chondrocytes to induce OA pathogenesis.
There are several potential limitations to our study. First, it was
previously shown that the development of histologic OA fol-
lowing DMM in mice is associated with poor functional outcomes
Fig. 2 Oscar-−/− mice exhibit reduced OA pathogenesis. a–d Experimental OA was examined by safranin-O staining (a) and scoring of OA parameters,
including articular cartilage destruction (OARSI grade) (b), SBP thickness (c), and ratio of hyaline cartilage (HC) to the calcified cartilage (CC) (d) in WT
and Oscar−/− mice. Oscar−/− and WT mice underwent sham or DMM surgery for 8 weeks. Scale bar= 50 μm. e Representative 3D reconstructed micro-
CT images and quantitative analysis of mouse tibia subchondral bone plates at 8 weeks post DMM surgery compared with that of the sham control. Scale
bars= 1000 μm. Error bars represent mean ± S.E.M. of n= 10 mice (b–e). f, g qRT-PCR analysis of articular cartilage tissue of WT and Oscar−/− mice
subjected to sham or DMM surgery with error bars representing mean ± S.E.M. of n= 10 mice. h, i IHC analyses of MMP3, MMP13 and ADAMTS5 (h),
aggrecan and COL2A1 (i) in OA articular cartilage from DMM surgery mice compared with sham-operated mice (n= 10). Scale bar= 50 μm. Two-way
ANOVA was performed followed by Sidak’s Multiple Comparison’s test, with p values indicated in figure.
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including pain58,59. The data presented in this study demonstrate
that the collagen–OSCAR interaction contributes to cartilage and
joint degeneration following DMM, and consistent with prior
works58,59. Such pathologic changes are expected to result in pain
and impaired motile function. Future studies are required to
further determine the role of OSCAR in OA-associated pain and
joint dysfunction. Second, while our findings demonstrate that
OSCAR is increased in OA chondrocytes in humans and in
murine chondrocytes stimulated with the OA-associated pro-
inflammatory cytokine IL-1β, further investigation is needed to
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In addition, we developed OSCAR-Fc fusion proteins that
inhibit pathological OA pathogenesis. Although OA, the most
common form of arthritis, is the leading cause of disability,
there is no effective disease-modifying therapy. Thus, the devel-
opment of strategies to disrupt the OSCAR–collagen interaction
with biologics, such as Fc fusion proteins and neutralizing anti-
bodies, or small molecules may provide potential therapeutics
for OA.
Collectively, our findings demonstrate that dysregulation of the
OSCAR–collagen interaction caused by OSCAR deficiency affects
chondrocyte apoptosis via the downregulation of TRAIL
expression in OA pathogenesis, and OSCAR-Fc fusion proteins
blocked OA pathogenesis. Thus, our results suggest that OSCAR
acts as a catabolic regulator of cartilage degeneration via chon-
drocyte apoptosis, and support that OSCAR could be a ther-
apeutic target for OA.
Methods
Experimental OA in mice. C57BL/6J (WT) male mice and OSCAR-deficient mice
(Oscar−/−, C57BL/6) were used for experimental OA studies. We purchased 8–10-
week-old C57BL/6 male mice from Japan SLC, Inc. (Hamamatsu, Japan); C57BL/6
Oscar−/− mice have been described previously16. Experimental OA was induced by
IA injection of collagenase27,28 in 8–10-week-old male mice or by DMM
surgery25,28,29 in 10–12-week-old male mice. To induce collagenase-induced OA,
mice were injected with 10 U of collagenase dissolved in 10 μl phosphate-buffered
saline (pH 7.4) at the right knee joint space through the IA space along the patellar
tendon. The collagenase type VII (from Clostridium histolyticum, enzyme activity
> 500 U) was purchased from Sigma-Aldrich (St Louis, MO, USA). In DMM
surgery, the medical meniscus ligament was surgically removed from the right knee
joint of hind limb. Mice injected with phophate0buffered saline or sham-operated
mice were used as controls. The mice were euthanized at 1, 2, 4, or 8 weeks after
OA induction. To study the protective effects of OSCAR-Fc from induced OA, we
prepared soluble hOSCAR-Fc fusion protein by fusing the non-cytoplasmic
domain of human OSCAR to the Fc part of human immunoglobulin G1 (IgG1).
We injected 2 mg kg−1 of hOSCAR-Fc fusion protein or 2 mg kg−1 of an isotype-
matched IgG1 control once per week for 4 or 8 weeks, beginning 1 week after IA
collagenase injection or DMM surgery, respectively. The mice were euthanized at 5
or 9 weeks after OA induction and subjected to biochemical and histological
analyses. All mice were maintained in pathogen-free barrier facilities. Mice were
housed in barrier facility at 5 or less per cage at 24–26 °C with humidity ranging
between 30 and 60% with 12 h light/dark cycles. For each experiment, age- and sex-
matched mice were used and randomly allocated to each experimental group. All
animal experiments were approved by the Institutional Animal Care and Use
Committees (IACUC) (Protocol No: IACUC 19-027) of Ewha Womans University
and followed National Research Council Guidelines.
Human samples. Cartilage tissues with OARSI grade 6 were obtained from ten
patients with OA ranging in age from 63 to 78 years (three males and seven
females) during total knee replacement surgery. To rule out the effects of other
underlying diseases, OA patients had no RA, metabolic disease, or other inflam-
matory diseases at the time of surgery (Source data Fig. 1c). The institutional
review board of Yonsei University (Protocol No: IRB 3-2018-0251), Gangnam
Severance Hospital, South Korea, approved the use of the articular cartilage. All
participants provided informed consent.
Micro-CT analyses. To analyze knee joints, samples were isolated from 10- to 12-
week-old male WT and Oscar−/− mice subjected to DMM surgery. The samples
were fixed in 10% formaldehyde and scanned using a Skyscan 1176 in vivo μCT
scanner (Bruker micro-CT, Kontich, Belgium) at 75 kV and 333 μA. A total of 360°
views were acquired at 0.7° angle increments, each for an exposure time of 260 ms,
to give a resolution of 18 μm. The raw data from the tibiae acquired by micro-CT
were translated into two-dimensional cross-sectional gray scale image slices using
NRecon (Bruker microCT, Kontich, Belgium). From the acquired two-dimensional
images, structural parameters of the tibial trabecular bone were evaluated by a CT
Analyzer (CT-AN, v1.10.9.0, Bruker microCT, Kontich, Belgium), including SBP
thickness (μm) and the bone volume fraction (BV, mm3).
Histology and immunohistochemistry. At the end of the experiments, the knee
joints of the mice were fixed in 10% formaldehyde at 4 °C for >48 h, decalcified in
0.5 M ethylenediaminetetraacetic acid in PBS (pH 7.4) for 14 days, and embedded
in paraffin. Next, the paraffin blocks were cut into 5 μm sections and stained with
hematoxylin and eosin and safranin-O. Articular cartilage destruction was scored
using OARSI grades (0–6), a standard OA-grading system25,30, while sclerosis and
articular cartilage destruction were identified by safranin-O staining and measured
using OsteoMeasureXP (OsteoMetrics, Inc., Atlanta, GA, USA), Adobe photoshop
(v19.1.3, San Jose, CA, UA), and an Olympus DP72 charge-coupled device camera
(v2.1, Olympus Corporation, Tokyo, Japan). Subchondral bone sclerosis was
determined by measuring the SBP thickness3. Immunostaining was performed
using a standard protocol. The knee joint sections were incubated with primary
anti-OSCAR antibody (Cat# SC34235, Santa Cruz Biotechnology, 1:200 dilution)
at 4 °C overnight. To detect immunoactivity, we used a 3,3′-diaminobenzidine
peroxidase (horseradish peroxidase) substrate detection kit (Vector Laboratories,
Inc., Burlingame, CA, USA) and counterstained with hematoxylin. Additional
immunostaining was performed using antibodies against MMP3 (Cat# Ab53015,
Abcam, 1:50 dilution), MMP13 (Cat# Ab51072, Abcam, 1:25 dilution), aggrecan
(Cat# Ab1031, Abcam, 1:100 dilution), COL2A1 (Cat# MAB8887, Sigma-Aldrich,
1:50 dilution), ADAMTS5 (Cat# GTX100332, Genetex, 1:50 dilution), OPG (Cat#
sc8468, Santa Cruz Biotechnology, 1:200 dilution), and TRAIL (Cat# AF1121,
R&D System, 1:200 dilution). Articular chondrocyte apoptosis was determined
using the TUNEL assay and a kit from Millipore (Temecula, CA, USA). The
specimens were visualized under a fluorescence microscope and the number of
apoptotic articular chondrocytes in relation to the total number of cells was
counted.
Primary culture of articular chondrocytes. Articular chondrocytes were isolated
from femoral condyles and tibial plateaus of 4–5-day-old Institute of Cancer
Research mice by digestion with 0.2% collagenase type II60. The chondrocytes were
maintained in Dulbecco’s modified Eagle’s medium (DMEM; HyClone, Logan, UT,
USA) containing 10% fetal bovine serum and were treated with 5 ng mL−1 of IL-1β
or 50 ng mL−1 of TNF-α for 48 h. Oscar-specific siRNAs were designed with the
coding sequences of mouse Oscar, which are shown in Supplementary Table 1.
Chondrocytes were cultured for 60 h and transfected for 7–8 h with siRNAs using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Transfected cells were
exposed for 2 h with 50 UmL−1 collagenase type VII (Sigma-Aldrich, St Louis,
MO, USA), before being treated with IL-1β for 48 h. Non-silencing siRNA was used
as a negative control. Articular chondrocytes were isolated from femoral condyles
and tibial plateaus of 2–3-day-old WT and Oscar−/− mice. Chondrocytes were
exposed for 2 h with 50 UmL−1collagenase, then preincubated for 30 min with 1 μg
mL−1 TRAIL neutralizing antibody (Cat# 14-5951-82, Thermo Fisher Scientific),
before being treated with IL-1β. Rat IgG2a kappa isotype (Cat# 12-4321-80,
Thermo Fisher Scientific) was used as a negative control. Chondrocytes were
incubated for 2 h with 5 μM of an OSCAR-binding triple-helical peptide, before
being treated with IL-1β or 10 μg mL−1 hOSCAR-Fc fusion protein. Articular
chondrocyte apoptosis was determined using the TUNEL assay and a kit from
Millipore (Temecula, CA, USA). The OSCAR-binding triple-helical peptide was
synthesized by Peptron (Daejeon, Korea), and the purity was analyzed using high-
performance liquid chromatography. A triple-helical-forming peptide16,19,20
composed of the minimal binding motif (GPO)3GPOGPAGFO(GPO)2G was used
for western blot and quantitative reverse transcription polymerase chain reaction
analyses.
Fig. 3 OSCAR regulates OA pathogenesis via TRAIL-induced articular chondrocyte apoptosis. a Selection of putative Oscar targets involved in OA
pathogenesis. Venn diagram indicating the number of genes attenuated in articular cartilage Oscar−/− mice after DMM surgery (left). Hypergeometric p
value measuring the significance of enrichment is depicted. Gene-wise scaled gene expression patterns of 1270 common genes in each sample are shown
(right). b Functional annotations significantly enriched for 1270 common genes. Hypergeometric tests were performed using the hallmark gene annotation
in MsigDB, yielding enrichment scores, defined as −log10 (FDR). c Simplified apoptotic signaling pathway altered by Oscar deficiency. Each gene is colored
with the DIF score, defined as the extent to which gene expression is altered by Oscar deficiency. A negative DIF indicates transcriptional suppression in
Oscar−/− mice. The network was visualized by Cytoscape v3.7 software. d, e qRT-PCR (d) and IHC (e) analyses of TRAIL in OA articular cartilage from
DMM surgery mice compared to sham-operated mice. Scale bar= 50 μm. f, gmRNA levels (f) and immunostaining (g) for OPG in articular cartilage tissue
from sham surgery or DMM surgery mice. Scale bar= 50 μm. h, i Apoptotic articular chondrocytes were detected and quantified by TUNEL assay. Scale
bar= 25 μm. Error bars represent mean ± S.E.M. of n= 10 mice (d–g, i). Two-way ANOVA was performed followed by Sidak’s Multiple Comparison’s test,
with p values indicated in figure.
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Generation of hOSCAR-Fc fusion protein. For these experiments, 293F cells were
transfected with a gene encoding the dimeric form of the extracellular domains
(amino acids 19–233) of human OSCAR with the Fc region of human IgG1 cloned
into pVITRO1-Fc. The secreted purified protein (hOSCAR-Fc) was loaded into a
Thermo Scientific™ Pierce™ Protein G-Sepharose bead column (Thermo Fisher
Scientific, Waltham, MA, USA) and eluted with an elution buffer (100 mM glycine,
pH 2.0, and 1M Tris-Cl, pH 7.0; Duchefa Biochemie B.V., Haarlem, the
Netherlands) to immediately neutralize the protein. The tubes containing high
concentrations of protein were collected, extensively dialyzed against PBS, and kept
frozen at −80 °C.
RNA isolation and real-time PCR. Total RNAs were isolated from primary
chondrocytes using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) or from
P < 0.0001
P < 0.0001
P = 0.0011 P < 0.0001
P < 0.0001
P < 0.0001
P < 0.0001 P < 0.0001

















































































































































































































































– + – +
– – + +





























































































































































































































































































































































































































































































































ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18208-y
8 NATURE COMMUNICATIONS |         (2020) 11:4343 | https://doi.org/10.1038/s41467-020-18208-y | www.nature.com/naturecommunications
mouse and human knee joint tissues using the RNA Mini Kit (Life Technologies,
Carlsbad, CA, USA) and reverse-transcribed to generate complementary
DNA (cDNA) using the Superscript cDNA synthesis kit (Invitrogen) according
to the manufacturer’s instructions. Real-time PCR was performed using the
KAPA SYBR Green fast qPCR kit (Kapa Biosystems, Inc., Wilmington, MA,
USA) on a StepOnePlus real-time PCR machine (Applied Biosystems, Foster
City, CA, USA). The samples were analyzed in triplicate and data were nor-
malized to β-actin mRNA expression. See Supplementary Table 2 for primer
sequences.
Fig. 4 OSCAR–collagen binding co-stimulates IL-1β-induced apoptotic signaling in articular chondrocytes. a Caspase activity in mouse articular
chondrocytes treated with IL-1β (5 ng mL−1) and collagenase (Coll, 50 UmL−1). b, c qRT-PCR analysis (b) and western blotting (c) in mouse articular
chondrocytes. Chondrocytes were either untreated or transfected with control siRNA (C-siRNA) (100 nM) or siRNAs specific for mouse Oscar and
exposed to IL-1β (5 ngmL−1) and collagenase (50 UmL−1) for 48 h. d Articular chondrocyte viability was quantified by MTT assay. Error bars represent
mean ± S.E.M. of n= 5 wells. e Caspase-8 and caspase-3 activity was measured using the respective assay kits. f, g qRT-PCR analysis (f) and western
blotting (g) in mouse articular chondrocytes. Chondrocytes were treated with hIgG or hOSCAR-Fc (10 μg ml−1) with collagenase and exposed to IL-1β for
48 h. h Apoptotic articular chondrocytes were detected and quantified by TUNEL assay. Scale bar= 100 μm. i, j qRT-PCR analysis (i) and western blotting
(j) in mouse articular chondrocytes treated with 10 μΜ OSCAR-binding triple-helical peptide before IL-1β treatment. Articular chondrocytes were treated
with hOSCAR-Fc for 48 h. Error bars shown in a, b, e, f, h and i are mean ± S.E.M. for n= 4 independent experiments. One-way ANOVA was performed














































































































































































Fig. 5 OSCAR-Fc blocks OA pathogenesis in mice. WT mice subjected to sham or DMM surgery were IA-injected with human IgG as a control or
hOSCAR-Fc (2mg kg−1) to block OSCAR in joint tissue. Articular cartilage sections were subjected to safranin-O staining (a) and quantitative analysis of
OARSI grade (b), SBP thickness (c), and ratio of hyaline cartilage (HC) to calcified cartilage (CC) (d). Scale bar= 50 μm. Error bars represent mean ± S.E.
M. of n= 10 mice (b–d). e–g IHC analyses of MMP3, MMP13, and ADAMTS5 (e), aggrecan and COL2A1 (f), and TRAIL and OPG (g) in articular cartilage
tissue from sham surgery or DMM surgery mice (n= 10). Scale bar= 50 μm. h, i Apoptotic articular chondrocytes were detected and quantified by TUNEL
assay. Scale bar= 25 μm. Error bars represent mean ± S.E.M. of n= 10 mice (i). Two-way ANOVA was performed followed by Sidak’s Multiple
Comparison’s test, with p values indicated in figure.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18208-y ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4343 | https://doi.org/10.1038/s41467-020-18208-y | www.nature.com/naturecommunications 9
Western blotting analysis and immunoprecipitation. Articular chondrocytes
were extracted with lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5%
deoxycholate acid, and 1% NP-40) containing protease and phosphatase inhibitors.
For western blotting analysis, antibodies raised against OSCAR (Cat# PA5-47171,
Thermo Fisher Scientific, 1:1000 dilution), OPG (Cat# sc8468, Santa Cruz Bio-
technology, 1:1000 dilution and Cat# ab183910, Abcam, 1:1000 dilution), and
TRAIL (Cat# ab10516, Abcam, 1:1000 dilution) were used. In addition, β-actin
(Cat# sc47778, Santa Cruz Biotechnology, 1:1000 dilution) and glyceraldehyde-3-
phosphate dehydrogenase (Cat# sc32233, Santa Cruz Biotechnology, 1:1000 dilu-
tion) antibody was used as a loading control. Source data file contains the
uncropped gel scans of western blots.
Caspase assay. Caspase-3 and caspase-8 activities were determined using a cas-
pase colorimetric assay kit (Biovision Research Products, Milpitas, CA, USA)60.
Briefly, articular chondrocyte lysates were incubated with a substrate for caspase-3
(DEVD-pNA) or caspase-8 (IETD-pNA) at 37 °C for 2 h. The activity of each
caspase was determined by measuring the absorbance at 405 nm.
MTT assay. Primary articular chondrocytes were transfected with control short
interfering RNA, or si-Oscar in the presence of 50 UmL−1 of collagenase and 5 ng
mL−1 of IL-1β for 48 h. Then, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT) was added to the culture medium in each well, and the
samples were incubated at 37 °C for 4 h. Dimethyl sulfoxide was added to each well
at room temperature for 10 min, after which absorbance was measured at an
optical density of 570 nm.
RNA sequencing and data analysis. Total RNA was extracted using the RNA
Mini Kit (Life Technologies, Carlsbad, CA, USA) from knee joint tissues of WT
and Oscar−/− mice euthanized at 2 or 4 weeks after sham or DMM surgery. Each
group consisted of a combination of ten murine articular cartilages. Sequencing
libraries were prepared according to the manufacturer’s instructions (TruSeq
Stranded mRNA Library Prep Kit; Illumina, San Diego, CA, USA). Paired-end
sequencing of 101-mer read length was performed using a HISEQ 2500 sequencing
system (Illumina). The sequencing quality of raw FASTQ files was assessed using
FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Low-quality
reads and adapter sequences in reads were eliminated using BBDuk (http://jgi.doe.
gov/data-and-tools/bb-tools/). Trimmed reads were aligned to the GRCm38 gen-
ome reference using STAR aligner (v2.6.0a). Gene level TPM was calculated using
RSEM (v1.2.17) with Gencode v22 annotation. FASTQ files and processed data are
available from the Gene Expression Omnibus (GEO: GSE147529) database.
To identify Oscar downstream mechanisms involved in OA pathogenesis, we
roughly selected genes that met the following four requirements: (i) log2(EDMM/
Esham) in Oscar−/− mice < 0, where Ex was the gene expression value (TPM) in
cartilage undergoing x-operations; (ii) log2(EDMM/Esham) in WT mice > 0; (iii) DIF
< DIF25%, where DIF was defined as the difference between log2(EDMM/Esham) in
KO mice and log2(EDMM/Esham) in WT mice, and DIF25% was the lower quartile
value of DIF values for a total of 12,597 genes; and (iv) all three requirements (i)–
(iii) were met in the data obtained at 2 and 4 weeks. For functional enrichment
analysis for the 1270 genes, we performed hypergeometric tests using the hallmark
gene set in the Molecular Signatures Database (http://software.broadinstitute.org/
gsea/msigdb). Subsequent multiple testing corrections were done through false
discovery rate estimation. Annotated human genes were mapped to mouse genes
using MGI (http://www.informatics.jax.org) human/mouse orthology information.
The network was visualized by Cytoscape v3.7 software61.
Quantitation and statistical analysis. All data were collected from at least four
independent experiments. Statistical analysis was performed using a Student’s two-
tailed t test to analyze differences between two samples. The analysis of more than
two samples was performed using one-way and two-way analysis of variance
(ANOVA), followed by pairwise multiple comparisons if significant. Data based on
the comparison of two samples with a variable measured using an ordinal grading
system were analyzed using the Sidak’s multiple comparisons test. Multiple com-
parisons were performed using the Dunnett’s test or Tukey’s test and one-way
ANOVA. The sample size for each experiment was not predetermined. P values are
indicated in the figures or in source data, and the error bars represent standard
error of the mean (S.E.M.) for parametric data and calculated 95% confidence
intervals for non-parametric data. All the graphs and statistical analysis were
performed using GraphPad Prism (v8.1.2, San Diego, CA, USA).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available within the article and
its Supplementary Information files or from the corresponding author upon reasonable
request. RNA seq of articular cartilage in WT and Oscar−/− mice can be obtained from
the Gene Expression Omnibus (GEO) database with accession number GSE147529. The
following figures have associated raw data: Figs. 1a–c, 2b–h, 3d–i, 4a, b, d–f, h, i, and
5b–f; Supplementary Figs. 1a–g, 2b–h, 3f, g, i, 4b–d, f, and 5b–i. Source data are provided
with this paper.
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